Stomach Carcinoma  >>  NGC-capecitabine (PCS6422)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NGC-capecitabine (PCS6422) / Processa Pharma
NCT00264472: A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors

Suspended
1
60
US
ADH300004
Adherex Technologies, Inc.
Neoplasms
06/09
 

Download Options